| The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings RW Paterson, RL Brown, L Benjamin, R Nortley, S Wiethoff, T Bharucha, ... Brain 143 (10), 3104-3120, 2020 | 1211 | 2020 |
| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 544 | 2019 |
| 4MOST: Project overview and information for the First Call for Proposals RS De Jong, O Agertz, AA Berbel, J Aird, DA Alexander, A Amarsi, ... arXiv preprint arXiv:1903.02464, 2019 | 447 | 2019 |
| Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome S Keddie, J Pakpoor, C Mousele, M Pipis, PM Machado, M Foster, ... Brain 144 (2), 682-693, 2021 | 309 | 2021 |
| Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease A Heslegrave, W Heywood, R Paterson, N Magdalinou, J Svensson, ... Molecular neurodegeneration 11, 1-7, 2016 | 287 | 2016 |
| Increased CSF neurogranin concentration is specific to Alzheimer disease H Wellington, RW Paterson, E Portelius, U Törnqvist, N Magdalinou, ... Neurology 86 (9), 829-835, 2016 | 246 | 2016 |
| A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes NK Magdalinou, RW Paterson, JM Schott, NC Fox, C Mummery, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (11), 1240-1247, 2015 | 241 | 2015 |
| Biomarkers in dementia: clinical utility and new directions RM Ahmed, RW Paterson, JD Warren, H Zetterberg, JT O'brien, NC Fox, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (12), 1426-1434, 2014 | 189 | 2014 |
| Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay WE Heywood, D Galimberti, E Bliss, E Sirka, RW Paterson, ... Molecular neurodegeneration 10, 1-16, 2015 | 159 | 2015 |
| Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre RW Paterson, MS Zandi, R Armstrong, A Vincent, JM Schott Journal of Neurology, Neurosurgery & Psychiatry 85 (6), 625-630, 2014 | 151 | 2014 |
| Imaging biomarkers in neurodegeneration: current and future practices PNE Young, M Estarellas, E Coomans, M Srikrishna, H Beaumont, ... Alzheimer's research & therapy 12, 1-17, 2020 | 148 | 2020 |
| 36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 March 2016 RM Bateman, MD Sharpe, JE Jagger, CG Ellis, J Solé-Violán, ... Critical care 20, 13-182, 2016 | 146 | 2016 |
| Differential diagnosis of Jakob-Creutzfeldt disease RW Paterson, CC Torres-Chae, AL Kuo, T Ando, EA Nguyen, K Wong, ... Archives of neurology 69 (12), 1578-1582, 2012 | 132 | 2012 |
| Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta C Arber, J Toombs, C Lovejoy, NS Ryan, RW Paterson, N Willumsen, ... Molecular Psychiatry 25 (11), 2919-2931, 2020 | 127 | 2020 |
| Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes MS Zandi, RW Paterson, MA Ellul, L Jacobson, A Al-Diwani, JL Jones, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (7), 708-713, 2015 | 125 | 2015 |
| Pain and temperature processing in dementia: a clinical and neuroanatomical analysis PD Fletcher, LE Downey, HL Golden, CN Clark, CF Slattery, RW Paterson, ... Brain 138 (11), 3360-3372, 2015 | 117 | 2015 |
| Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging TD Parker, CF Slattery, J Zhang, JM Nicholas, RW Paterson, AJM Foulkes, ... Human brain mapping 39 (7), 3005-3017, 2018 | 116 | 2018 |
| ApoE influences regional white-matter axonal density loss in Alzheimer's disease CF Slattery, J Zhang, RW Paterson, AJM Foulkes, A Carton, ... Neurobiology of aging 57, 8-17, 2017 | 107 | 2017 |
| Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic RW Paterson, CF Slattery, T Poole, JM Nicholas, NK Magdalinou, ... Alzheimer's research & therapy 10, 1-11, 2018 | 106 | 2018 |
| Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy TJ Shakespeare, D Kaski, KXX Yong, RW Paterson, CF Slattery, NS Ryan, ... Brain 138 (7), 1976-1991, 2015 | 99 | 2015 |
